The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 12 members with Giovanni Caforio as chair. Download the ...

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Enables manufacturing of medicines across company’s main therapeutic ...

Career Search Explore opportunities with Novartis below. Notice to applicants for US job openings. Learn More Be aware of fake job advertisements and job offers. Novartis is aware of employment scams ...

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations. ECN members are chosen by the Board of Directors.

We’re discovering and manufacturing our innovative medicines right here to help more patients across the United States. For the first time in our history, Novartis will be able to deliver end-to-end ...

Learn about Novartis annual results, including media releases, annual reports, webcasts and presentations, and year-to-date figures.

The purpose of this study is to characterize the effect on dengue viral load, fever clearance time as well as on clinical signs and symptoms with the treatment of EYU688 compared with placebo in ...

Basel, December 21, 2018 - Novartis today announced that it has completed the acquisition of Endocyte, Inc., a US-based biopharmaceutical company focused on developing radioligand and CAR-T therapies ...

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. We are exploring possibilities to cure disease, intervene earlier in chronic ...

Novartis anuncia los resultados financieros del cuarto trimestre y del año completo 2024 de la compañía. Informe Integrado Novartis en la Sociedad 2024 Lee más sobre nuestro desempeño en relación con ...

Our research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible. Novartis works closely with healthcare professionals around the work ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...